| Literature DB >> 30496556 |
Jackie Cook1, Chrispin Owaga2,3, Elizabeth Marube2, Amrish Baidjoe4, Gillian Stresman1, Robin Migiro3, Jon Cox1, Chris Drakeley1, Jennifer C Stevenson5,6.
Abstract
BACKGROUND: Malaria transmission in African highland areas can be prone to epidemics, with minor fluctuations in temperature or altitude resulting in highly heterogeneous transmission. In the Kenyan Highlands, where malaria prevalence has been increasing, characterising malaria incidence and identifying risk factors for infection is complicated by asymptomatic infection.Entities:
Keywords: zzm321990 Plasmodium falciparumzzm321990 ; Kenya; cohort; heterogeneity; highlands; malaria
Mesh:
Year: 2019 PMID: 30496556 PMCID: PMC6391934 DOI: 10.1093/trstmh/try122
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN: 0035-9203 Impact factor: 2.184
Figure 1.Location of cohort study site within the Kenyan Highlands. Inset: location of the study area within Kenya.
Baseline characteristics of the cohort population
| Household characteristics | |
| Altitude of household (average, range) | 1508 m (1437–1628) |
| Households | 974 |
| Households sprayed in the last 12 months | 47.5% (463) |
| SES (household level) | |
| Highest | 27.4% (265) |
| High | 16.1% (156) |
| Moderate | 22.1% (214) |
| Low | 15.0% (145) |
| Lowest | 19.3% (187) |
| Households with at least one bed net | 62.7% (611) |
| Number of bed nets owned per house (median, range) | 2 (1–8) |
| Households with open eaves | 84.9% (827) |
| Participant characteristics | |
| People recruited | 3155 |
| Age (median, range) | 13 years (6 months–105 years) |
| Sex | |
| Female | 54% (1698) |
| Male | 46% (1454) |
| Proportion travelling outside of EA within the past 3 months | 5.9% (183) |
| Reporting using a net last night | 41.9% (1320) |
| Anaemic (Hb<11 g/dl) | 15.5% (489) |
| RDT-positive | 1.5% (48) |
Figure 2Incidence per month in each district (95% CI) and rainfall in the study area.
Characteristics of the population who experienced a malaria infection
| Number of cases | Follow-up time (years) | Incidence rate (per 1000 person-years) | Hazard ratio (95% CI) | P value | |
|---|---|---|---|---|---|
| Sex | |||||
| Female | 315 | 1579 | 199.4 | 1.0 | 0.156 |
| Male | 306 | 1366 | 224.1 | 1.1 (0.9–1.3) | |
| Age group (years) | |||||
| 0–5 | 134 | 571 | 234.6 | 1.0 | 0.006 |
| 5–15 | 228 | 568 | 225.2 | 1.1 (0.8–1.4) | |
| 15–25 | 63 | 443 | 162.2 | 0.8 (0.6–1.2) | |
| 25–50 | 78 | 232 | 140.5 | 0.6 (0.4–1.0) | |
| 50–100 | 59 | 104 | 180.9 | 0.7 (0.5–0.9) | |
| Socioeconomic status | |||||
| Highest | 100 | 703 | 142.2 | 1.0 | 0.026 |
| High | 67 | 465 | 144.2 | 1.0 (0.6–1.6) | |
| Medium | 129 | 664 | 194.4 | 1.4 (0.9–1.9) | |
| Lower | 103 | 451 | 228.4 | 1.6 (1.0–2.6) | |
| Lowest | 159 | 570 | 278.7 | 1.9 (1.2–3.2) | |
| Altitude (m) | |||||
| 1437–1488 | 139 | 735 | 188.9 | 1.0 | 0.618 |
| 1489–1508 | 159 | 737 | 215.8 | 1.1 (0.9–1.4 | |
| 1509–1526 | 129 | 676 | 190.8 | 1.0 (0.8–1.3) | |
| 1527–1628 | 137 | 714 | 191.96 | 1.0 (0.8–1.3) | |
| Spray status | |||||
| Not sprayed in last 12 months | 155 | 145 | 107.1 | 1.0 | <0.001 |
| Sprayed in last 12 months | 413 | 143 | 288.9 | 2.7 (1.8–3.9) | |
| Net use | |||||
| Did not use a net | 336 | 168 | 200.3 | 1.0 | 0.742 |
| Used a net | 232 | 119 | 193.4 | 0.9 (0.8–1.2) | |
| Travel outside of EA | |||||
| No | 508 | 2681 | 189.5 | 1.0 | 0.045 |
| Yes | 52 | 17 | 313.7 | 1.7 (1.0– 2.7) | |
| Infection status at recruitment | |||||
| Not infected | 545 | 2830 | 192.6 | 1.0 | <0.001 |
| Infected | 21 | 45 | 468.7 | 2.4 (1.6–3.7) |
Results from adjusted multi-variable Poisson regression
| Covariate | Category | Adjusted hazard ratio | P value |
|---|---|---|---|
| Age group (years) | 0–5 | 1.0 | 0.011 |
| 5–10 | 1.1 (0.9–1.5) | ||
| 10–15 | 0.9 (0.6–1.2) | ||
| 15–20 | 0.7 (0.5–1.1) | ||
| >20 | 0.7 (0.5–0.9) | ||
| SES | Highest | 1.0 | 0.016 |
| High | 1.1 (0.7–1.8) | ||
| Medium | 1.5 (1.0–2.1) | ||
| Lower | 1.8 (1.2–2.7) | ||
| Lowest | 2.1 (1.3–3.3) | ||
| Travel outside of the EA | No | 1.0 | 0.024 |
| Yes | 1.8 (1.1–3.0) | ||
| Infection status at recruitment | Not infected | 1.0 | <0.001 |
| Infected | 2.6 (1.7–4.1) |
Figure 3.Infection incidence per 1000 person-years in the 40 cohort study clusters.